SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma
Clinical trial NCT03363555 · UNKNOWN
Trial details
- NCT number
- NCT03363555
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2019-06-30
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.